Enara Bio
Advancing cancer immunotherapy by targeting the unconventional
66 employees · est. 2016 · Oxford, United Kingdom
Enara Bio is the older company (2016 vs 2019); Enara Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Enara Bio | Mnemo Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2019 |
| Headquarters | ||
| Headquarters | Oxford, United Kingdom | Paris, France |
| Employees | ||
| Employees | 66 larger | 16 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $50.00M | $75.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Development of cancer immunotherapies, Discovery of novel Dark Antigens, Optimization of bispecific T-cell engagers | Research and Development, Therapeutic Solutions, Scientific Publication Production |
| Target Customers | ||
| Target Customers | Cancer patients, Biopharmaceutical companies, Medical research institutions | Medical Researchers, Biopharmaceutical Industries, Healthcare Providers |
| Taxonomy | ||
| Taxonomy | Cancer Immunotherapy, Dark Antigen Discovery, Solid Tumor Treatment, T-cell Engagers, EDAPT Platform, EnTiCE Platform, Genomic Dark Matter, Bispecific T-cell Engagers, Therapeutic Cancer Vaccines, Endogenous Retroviral DNA, Novel Cancer Targets, Biopharmaceuticals, Life Science Collaboration, Immunotherapy Development | Immunotherapy, Cancer Detection, Cancer Treatment, Dark Genome, E-antigens, Cell Therapy, TCE (T-cell Engagers), ADC (antibody-drug Conjugates), Cancer Vaccines, Drug Discovery, EnfiniT Platform, Tumour-specific Targets, Therapeutic Modalities, In-silico Pipelines |
| Website | ||
| Website | enarabio.com | mnemo-tx.com |
About Enara Bio
Enara Bio, founded in 2016 and headquartered in the United Kingdom, is carving a niche in the Biotechnology and Health Care sectors by focusing on unconventional cancer immunotherapy. With their slogan, "Advancing cancer immunotherapy by targeting the unconventional," the company aims to revolutioni...
About Mnemo Therapeutics
Mnemo Therapeutics, founded in 2019, is a pioneering Paris-based biotechnology company, committed to transforming the landscape of cancer immunotherapy. With the guiding slogan, "Empower the body, cure the disease", Mnemo focuses on boosting the body's natural ability to identify and destroy cancer...
We will tell you when either one moves
BounceWatch watches Enara Bio and Mnemo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Enara Bio and Mnemo Therapeutics — by email.
Frequently Asked Questions
Compare Enara Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Enara Bio on 4 Feb 2026, and Mnemo Therapeutics on 17 Sep 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.